A federal appeals court handed Medtronic Inc. (NYSE:MDT) a win in a patent infringement lawsuit filed by Synthes Inc. subsidiary Spine Solutions Inc. over spinal implant technology.
The U.S. Court of Appeals for the Federal Circuit overturned portions of a lower court’s ruling in favor of SSI, pulling back at least $5.7 million in extra damages awarded for willful infringement and voiding a permanent injunction barring foreign sales of the allegedly infringing devices, Medtronic’s Maverick line of spinal implants.